ASPARAGINASE-SPECIFIC ANTIBODY MEASUREMENT IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) UNDER NATIVE E. COLI ASPARAGINASE-BASED AND ITS POTENTIAL FACTORS ASSOCIATION

被引：0
|
作者：
Techavichit, Piti [1 ]
Chaweephisal, Phumin [1 ]
Poparn, Hansamon [1 ]
Chiengthong, Kanhatai [1 ]
Lauhasurayotin, Supanun [1 ]
Sosothikul, Darintr [1 ]
机构：
[1] Dept Pediat, Integrat & Innovat Hematol Oncol Res Unit, Bangkok, Thailand
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP072
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Prothrombotic risk factors in children with acute lymphoblastic leukemia treated with delayed E. coli asparaginase (COALL-92 and 97 protocols)
    Mauz-Körholz, C
    Junker, R
    Göbel, U
    Nowak-Göttl, U
    THROMBOSIS AND HAEMOSTASIS, 2000, 83 (06) : 840 - 843
  • [22] IDENTIFICATION OF RISK FACTORS FOR HYPERSENSITIVITY REACTIONS TO PEG-ASPARAGINASE IN PEDIATRIC PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Dominick, Karissa
    Zembillas, Anthony
    Ketz, Jeff
    Hanna, Rabi
    Flagg, Aron
    Dahl, Elizabeth
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 95 - 95
  • [23] Outcomes Following Discontinuation of E. coli-asparaginase upon Severe Allergic Reactions in Children with Acute Lymphoblastic Leukemia
    Liang, Der-Cherng
    Yen, Hsiu-Ju
    Chang, Wan-Hui
    Liu, Hsi-Che
    Yeh, Ting-Chi
    Hung, Giun-Yi
    Wu, Kang-Hsi
    Peng, Ching-Tien
    Chang, Yu-Hsiang
    Chang, Te-Kao
    Hsiao, Chih-Cheng
    Sheen, Jiunn-Ming
    Chao, Yu-Hua
    Chang, Tai-Tsung
    Chiou, Shyh-Shin
    Lin, Pei-Chin
    Wang, Shih-Chung
    Lin, Ming-Tsan
    Ho, Wan-Ling
    Chen, Yu-Chieh
    BLOOD, 2015, 126 (23)
  • [24] Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia
    Mall, V
    Thomas, KB
    Sauter, S
    Niemeyer, CM
    Sutor, AH
    KLINISCHE PADIATRIE, 1999, 211 (04): : 205 - 210
  • [25] Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens
    Sarah M. Kashanian
    Noa G. Holtzman
    Ciera L. Patzke
    Jonathan Cornu
    Alison Duffy
    Madhurima Koka
    Sandrine Niyongere
    Vu H. Duong
    Maria R. Baer
    Jummai Apata
    Farin Kamangar
    Ashkan Emadi
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 817 - 826
  • [26] Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens
    Kashanian, Sarah M.
    Holtzman, Noa G.
    Patzke, Ciera L.
    Cornu, Jonathan
    Duffy, Alison
    Koka, Madhurima
    Niyongere, Sandrine
    Duong, Vu H.
    Baer, Maria R.
    Apata, Jummai
    Kamangar, Farin
    Emadi, Ashkan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (06) : 817 - 826
  • [27] ASSOCIATION OF THE DYNAMIC STATUS OF COAGULATION FACTORS WITH L-ASPARAGINASE ADMINISTRATION IN THE INDUCTION PHASE OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOBLASTIC LYMPHOMA
    Kubota, Y.
    Ikeda, Y.
    Oyama, C.
    Aoki, T.
    Isobe, K.
    Mori, M.
    Arakawa, Y.
    Hanada, R.
    Koh, K.
    HAEMATOLOGICA, 2015, 100 : 620 - 621
  • [28] Age-related changes in Hemostasis in children with Acute Lymphoblastic Leukemia; Influences of peg-asparaginase upfront and native E Coli asparaginase during, remission induction therapy
    Appel, Inge M.
    Pieters, Rob
    BLOOD, 2007, 110 (11) : 260A - 261A
  • [29] Efficacy and safety of recombinant E. coli-asparaginase in infants (less than one year of age) with acute lymphoblastic leukemia
    van der Sluis, Inge
    Moericke, Anja
    Escherich, Gabriele
    von Stackelberg, Arend
    Holter, Wolfgang
    Klingebiel, Thomas
    Flotho, Christian
    Legien, Sabine
    Tissing, Wim
    Bierings, Marc
    Guimbal-Schmolck, Cecile
    Pichlmeier, Uwe
    Kuehnel, Hans-Juergen
    Pieters, Rob
    HAEMATOLOGICA, 2013, 98 (11) : 1697 - 1701
  • [30] Erwinia asparaginase is less toxic than E.coli asparaginase in children with acute lymphoblastic leukemia (ALL): Results from the Dana-Farber cancer institute ALL consortium.
    Silverman, LB
    Dalton, VMK
    Zou, GY
    Su, JT
    Gelber, RD
    Schorin, M
    Moghrabi, A
    Asselin, B
    Sallan, SE
    BLOOD, 1999, 94 (10) : 290A - 290A
12345